SEEK Limited (ASX:SEK)
Australia · Delayed Price · Currency is AUD 24.41
+0.24 (0.99%)
Aug 5, 2025, 4:20 PM AEST
Sage Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2016 - 2020 |
Net Income | 12.8 | -100.9 | 1,046 | 168.8 | 752.2 | -113.1 | Upgrade |
Depreciation & Amortization | 53.8 | 36.3 | 33.5 | 31.2 | 49.8 | 76.7 | Upgrade |
Other Amortization | 102.5 | 102.5 | 73.6 | 58.5 | 83.5 | 1 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | 46.9 | 203.1 | Upgrade |
Loss (Gain) From Sale of Investments | 135.5 | 135.5 | -5.5 | -8.7 | -97 | 14.8 | Upgrade |
Loss (Gain) on Equity Investments | 146.4 | 146.4 | 31.4 | -5.3 | 4.6 | 39.9 | Upgrade |
Stock-Based Compensation | 17.6 | 17.6 | 18.9 | 14.7 | 21.1 | 17.2 | Upgrade |
Other Operating Activities | -111.7 | 7.8 | 12.5 | 118.6 | 55.4 | 35 | Upgrade |
Change in Accounts Receivable | -7.7 | -7.7 | -67.9 | -68.1 | -90.8 | 44 | Upgrade |
Change in Accounts Payable | -20.2 | -20.2 | 9.4 | 69.9 | 115.6 | 3.6 | Upgrade |
Change in Unearned Revenue | 0.7 | 0.7 | 37.5 | 33.9 | 22.1 | -50.2 | Upgrade |
Change in Income Taxes | 25.3 | 25.3 | -55.7 | -19.9 | 43.1 | -5.4 | Upgrade |
Change in Other Net Operating Assets | -3.4 | -3.4 | 10.5 | 7.4 | 6.5 | 2.9 | Upgrade |
Operating Cash Flow | 339.1 | 328.8 | 319.6 | 396.6 | 346.5 | 300 | Upgrade |
Operating Cash Flow Growth | 6.20% | 2.88% | -19.41% | 14.46% | 15.50% | -19.48% | Upgrade |
Capital Expenditures | -9.6 | -12.6 | -6.1 | -20.6 | -54.2 | -7.1 | Upgrade |
Cash Acquisitions | - | -0.9 | -0.3 | -6.1 | -1.2 | -4 | Upgrade |
Divestitures | 86.1 | 86.1 | - | -252.3 | 432.8 | - | Upgrade |
Sale (Purchase) of Intangibles | -131.7 | -156.4 | -172.9 | -112.3 | -83.7 | -85.7 | Upgrade |
Investment in Securities | -17.4 | -28.8 | 57.6 | -213.5 | 7.1 | -7.3 | Upgrade |
Other Investing Activities | -9.7 | -15.8 | -42.8 | 38.2 | -191.3 | -151.3 | Upgrade |
Investing Cash Flow | -82.3 | -128.4 | -164.5 | -570.8 | 109.1 | -256.6 | Upgrade |
Long-Term Debt Issued | - | 314.5 | 607.8 | 464.8 | 230.2 | 486.8 | Upgrade |
Long-Term Debt Repaid | - | -411 | -707.8 | -266.9 | -638.1 | -194.8 | Upgrade |
Net Debt Issued (Repaid) | -156.4 | -96.5 | -100 | 197.9 | -407.9 | 292 | Upgrade |
Issuance of Common Stock | 0.6 | 6.7 | - | - | - | - | Upgrade |
Common Dividends Paid | -124.8 | -149.6 | -159.6 | -152.2 | -45.8 | -47.8 | Upgrade |
Other Financing Activities | -15 | -8 | -15.4 | -49.9 | 1.7 | -52 | Upgrade |
Financing Cash Flow | -295.6 | -247.4 | -275 | -4.2 | -522.6 | 192.2 | Upgrade |
Foreign Exchange Rate Adjustments | 6.7 | -5 | 14 | 10.3 | -12.4 | -13.7 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | -32.2 | -33.6 | - | Upgrade |
Net Cash Flow | -32.1 | -52 | -105.9 | -200.3 | -113 | 221.9 | Upgrade |
Free Cash Flow | 329.5 | 316.2 | 313.5 | 376 | 292.3 | 292.9 | Upgrade |
Free Cash Flow Growth | 5.49% | 0.86% | -16.62% | 28.63% | -0.21% | -17.17% | Upgrade |
Free Cash Flow Margin | 31.02% | 29.17% | 27.07% | 33.68% | 38.45% | 45.02% | Upgrade |
Free Cash Flow Per Share | 0.92 | 0.89 | 0.88 | 1.06 | 0.82 | 0.83 | Upgrade |
Cash Interest Paid | 52.9 | 71.8 | 61.4 | 37.7 | 47.3 | 47.2 | Upgrade |
Cash Income Tax Paid | 56 | 53.7 | 126.5 | 112.9 | 42.7 | 38.2 | Upgrade |
Levered Free Cash Flow | 177.78 | 120.99 | 1,274 | 57.63 | -1,112 | 183.1 | Upgrade |
Unlevered Free Cash Flow | 225.09 | 167.8 | 1,317 | 86.56 | -1,082 | 217.48 | Upgrade |
Change in Net Working Capital | -29.2 | 6.6 | -1,115 | 128.7 | 1,242 | -121.4 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.